Esquivel, N. S. https://orcid.org/0000-0002-1389-8054
Tzeng, J. P.
Treiman, K.
Husick, C. H.
Sheridan, J.
Ortiz-Ravick, L.
Sae-Hau, M.
Brown, L.
DeMairo, K.
Bell, N.
Disare, K.
Weiss, E. S.
Funding for this research was provided by:
Leukemia and Lymphoma Society
AbbVie
Bristol-Myers Squibb
GlaxoSmithKline
Genentech
Biogen
Janssen Biotech
Karyopharm Therapeutics
Pfizer
Regeneron Pharmaceuticals
Royalty Pharma
Sanofi
Takeda Oncology
Article History
Accepted: 19 July 2024
First Online: 16 August 2024
Declarations
:
: The authors declare no competing interests.